|本期目录/Table of Contents|

[1]周建平,周伟平.大肝癌TACE后肿瘤组织VEGF、αv整合素表达及MVD变化[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):206-208.
 ZHOU Jian-ping,ZHOU Wei-ping.Expression of VEGF, integrin-αV and MVD in viable residual tumor tissues from large hepatocellular carcinoma after TACE[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(03):206-208.
点击复制

大肝癌TACE后肿瘤组织VEGF、αv整合素表达及MVD变化()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第12卷
期数:
2010年03期
页码:
206-208
栏目:
出版日期:
2010-05-20

文章信息/Info

Title:
Expression of VEGF, integrin-αV and MVD in viable residual tumor tissues from large hepatocellular carcinoma after TACE
文章编号:
1672-271X(2010)03-0206-03
作者:
周建平1周伟平2
1.315040 浙江宁波,解放军113医院普通外科;2.200438 上海,第二军医大学附属东方肝胆外科医院肝外三科
Author(s):
ZHOU Jian-ping1 ZHOU Wei-ping2
1.Department of General Surgery,113 Hospital of PLA,Ningbo,Zhejiang 315040,China;2.The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438,China
关键词:
肝细胞癌化疗栓塞血管内皮生长因子整合素微血管密度
Keywords:
hepatocellular carcinoma chemoembolization vascular endothelial growth factor Iintegrin microvessel density
分类号:
R735.7
DOI:
-
文献标志码:
A
摘要:
目的 观察大肝癌经导管动脉化疗栓塞(TACE)后残存肿瘤组织血管内皮生长因子(VEGF)、αv整合素表达及微血管密度(MVD)变化的意义。方法 96例大肝癌前瞻性分成术前TACE组40例(TACE组)与一期手术组56例(手术组),用免疫组化方法检测96例手术切除标本肿瘤组织VEGF、αv整合素表达及MVD值。 结果 术前TACE组肿瘤组织VEGF、αv整合素表达免疫反应积分显著高于手术组(分别为P=0.042,P=0.033),MVD 两者无显著差异(P=0.103)。结论 大肝癌术前TACE促使残存肿瘤组织VEGF及αv整合素的表达增高,有可能促进肿瘤细胞转移。
Abstract:
Objective To investigate the significance of expression of vascular endothelial growth factor (VEGF), integrin-αV and microvessel density (MVD)in viable residual tumor tissues from large hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE). Methods 96 patients with large HCC were divided to a preoperative TACE group (40 patients) and one-stage operation group (56 patients). Expression of VEGF, integrin-αV and MVD were examined in all viable residual tumor tissues of 96 patients using immunohistochemical staining. Results There were significant differences in the expression levels of VEGF and integrin-αV between preoperative TACE group and one-stage operation group ( P=0.042 and P=0.033). No significant difference was in MVD between two groups ( P=0.103). Conclusion TACE may enhance expression levels of VEGF and integrin-αV in viable residual tumor tissues from large HCC, and may promote cancer cells to metastasize.

参考文献/References:

[1] 肖恩华,胡国东,李锦清,等.经导管动脉化疗栓塞治疗肝细胞癌的疗效观察[J].中华肿瘤杂志,2005,27(8):478-482.
[2] Zhou WP,Lai EC,Li AJ,et al.A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma[J].Ann Surg ,2009,249(2):195-202.
[3] Cristofori C, Cardin R, Pivetta G, et al.Transcatheter arterial chemoembolization(TACE) in hepatocellular carcinoma(HCC):the role of angiogenesis and invasiveness[J]. Am J Gastroenterol,2008,103(4):914-921.
[4] 吴孟超.肝脏外科学[M].上海:上海科学技术文献出版社,2000:589-590.
[5] Poon RT,Ronnie TP.From molecular biology to targeted for hepatocellular carcinoma: the future is now[J]. Oncology,2007,72(1):30-44.
[6] Park JW,Lee JA,Park JE,et al.Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients[J].Hepatology,2007,46(2):446-455.
[7] Chen QM,Millar HJ,McCabe FL, et al. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models[J].Clin Cancer Res,2007,13(12):3689-3695.
[8] Mimoun N,Zakia H,Geraldine G,et al. Expression,Regulation,and Function of αv integrins in hepatocellular carcinoma:An in vivo and in vitro study[J]. Hepatology,2002,36(2):418-426.
[9] Kim HJ,Chung H,Yoo YG, et al.Inhibitor of DNA binding 1 actvates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1 alpha[J].Mol Cancer Res,2007,5(4):321-329.
[10]Tai MH, Huang CC, Wang CC, et al. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma(HCC) and adverse outcome of HCC patients[J]. J Surg Oncol,2008,98(5):349-357.

相似文献/References:

[1]曹清心,汪 晨,刘 宇,等.蜂毒素对人肝癌细胞中HMGB1及VEGF-C表达的影响[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):101.
 CAO Qing-xin,WANG Chen,LIU Yu,et al.Effect of melittin on high mobility group box 1 and vascular endothelial growth factors C expressions in hepatocarcinoma cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(03):101.
[2]沈国栋 综述,江淑芳 校审.肝细胞癌症围术期的输血治疗研究进展[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):184.[doi:10.3969/j.issn.1672-271X.2014.02.023]
[3]周昊,封冰综述,王锐审校.MicroRNA调控肝细胞癌EMT 和细胞外基质重塑的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):277.[doi:10.3969/j.issn.1672-271X.2020.03.012]
 ZHOU Hao,FENG Bing reviewing,WANG Rui checking.The research progress of MicroRNA to regulate EMT and extracellular matrix remodeling in hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(03):277.[doi:10.3969/j.issn.1672-271X.2020.03.012]
[4]郭晶晶,徐瀚峰,朱传东,等.N-myc下游调控基因1在肝细胞癌中的表达及其与预后的相关性[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):21.[doi:10.3969/j.issn.1672-271X.2021.01.001]
 GUO Jing-jing,XU Han-feng,ZHU Chuan-dong,et al.The expression and prognosis of NDRG1 in hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(03):21.[doi:10.3969/j.issn.1672-271X.2021.01.001]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2010-05-20